MindMed Releases Phase 1 Trial Results For Opioid Addiction | Microdose
Way back in 2019, before most of us knew what a shroom stock was, MindMed made one of the first ...
Way back in 2019, before most of us knew what a shroom stock was, MindMed made one of the first ...
A shroom boom is in the works, led by encouraging results from psychedelic medicine treatments for various issues associated with ...
-Positive topline results from COMP360’s Phase 2b study--RL-007 Phase 2a topline data in cognitive impairment associated with schizophrenia expected end ...
Prophecy DeFi Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third ...
Advertise your site, company or product to millions of web3, NFT and cryptocurrency enthusiasts. Learn more
© 2022 Altszn.com. All Rights Reserved.